Crucial Innovations Corp.
CINV
Other OTC4.55
USD
- -
- -
ISIN
US2287711012
CUSIP
228771101
Return %
Stock
S&P500
1Y
-62.05
18.21
3Y
7.06
63.29
5Y
7.06
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jon-Paul Doran
- Full Time Employees
- 1
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 120 Moorgate London United Kingdom EC2M 6UR
- IPO Date
- Sep 2, 2020
- Similar Companies
- Business
- Crucial Innovations Corp. (CINV) specializes in the cultivation, processing, and supply of cannabis-based products for medicinal use (CBPMs), including GMP-certified cannabis flower, oils, and extracts optimized for pharmaceutical-grade applications; it employs advanced hydroponic systems, sustainable LED lighting, and rigorous pheno-hunting techniques to produce terpene-rich strains with high THC levels and consistent quality across full-spectrum cannabinoids. The company maintains a vertically integrated seed-to-patient model encompassing cultivation oversight, laboratory testing for Certificates of Analysis (COAs), secure packaging, import/export logistics, and distribution partnerships with licensed clinics and dispensaries in the UK and Europe; its facilities feature SAHPRA-licensed, GMP-accredited indoor sites and a wholly owned greenhouse in South Africa, supported by world-class genetic specialists adhering to EU-GMP and GACP standards. Founded in 2018 and headquartered at 86-90 Paul Street, London, United Kingdom, CINV operates primarily in the global medical cannabis sector, targeting pharmaceutical suppliers, healthcare providers, and patients seeking treatments for various conditions while expanding production capacity through African operations. In November 2025, the company signed a Management Services Agreement with Cannabudgrow (Pty) Ltd, a Johannesburg-based licensed cultivator and exporter, under which CINV provides comprehensive management, administrative, and strategic oversight in exchange for 95% of net revenues post-compliance costs, enhancing its supply chain and footprint in emerging African markets. This follows a 2022 reverse merger acquiring medical cannabis operations in Zimbabwe from Eco Equity, valued at $210 million, which pivoted CINV into the sector and supported plans for substantial equity raises including a $25 million Regulation D/S offering and a $65 million Reg A in 2023.
Crucial Innovations Corp. Launches 4TP, a New Patient-Focused Brand of Cannabis-Based Products for Medicinal Use
Crucial Innovations Corp. Signs Management Services Agreement with South African Licensed Medicinal Cannabis Cultivator Cannabudgrow (Pty) Ltd
Crucial Innovations Corp. Appoints Rory Bowen to its Board of Directors
Crucial Innovations Corp To Acquire Eco Equity, a Medical Cannabis Operator in Zimbabwe Through Reverse Merger